Explore the latest in infectious diseases, including community-acquired and nosocomial disease, antibiotic use and stewardship, and more.
This cohort study examines rates of SARS-CoV-2 infection among patients with cancer receiving antitumor treatment.
This Viewpoint uses CDC data to compare the COVID-19 mortality rate in 2020 with prior leading causes of death (heart disease, cancer, lung disease, and injury) to put into context the cost of the infection in loss of life in the United States.
This cohort study assesses outcomes from early tracheostomy in the airway management of patients with COVID-19 requiring mechanical ventilation.
This randomized clinical trial examines whether prophylactic azithromycin is effective in preventing worsening of lung function and in reducing acute respiratory exacerbations in children with HIV-associated chronic lung disease taking antiretroviral therapy.
This comparative effectiveness review uses pooled clinical trial data to evaluate the similarity in the cause of bacterial conjunctivitis and in the treatment response between neonates and older children and adults.
This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.
This case report describes a patient with coronavirus disease 2019 who experienced severe ocular neuropathy with panuveitis, resulting in permanent loss of visual acuity.
This study compares all-cause excess mortality and COVID-19–related mortality during the early pandemic period (March-July 2020) with unintentional drug overdoses, the usual leading cause of death in young adults, during the same period in 2018 among adults aged 25 to 44 years.
In this Medical News article, Ala Stanford, MD, founder of Philadelphia’s Black Doctors COVID-19 Consortium, explains how she established COVID-19 testing sites for the city’s Black residents.
This cross-sectional study analyzes trends in suicidality by race/ethnicity during the coronavirus disease 2019 (COVID-19) pandemic.
This Viewpoint discusses 4 factors that explain transmission risk during aerosol-generating medical procedures.
This Viewpoint discusses individual- and system-level barriers and solutions for people with serious mental illness to access coronavirus disease 2019 vaccination when it is available.
This JAMA Patient Page reviews the US Preventive Services Task Force’s 2020 recommendation to screen for hepatitis B infection in adolescents and adults at increased risk (B recommendation).
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on screening for hepatitis B virus infection summarizes published evidence on the benefits and harms of screening and interventions for hepatitis B infection in nonpregnant adolescents and adults.
This 2020 US Preventive Services Task Force Recommendation Statement recommends screening for HBV infection in adolescents and adults at increased risk for infection (B recommendation).
This JAMA Live Highlights feature provides comments about the coronavirus 2019 pandemic from experts in clinical medicine, public health, and health policy expressed during livestream interviews with JAMA Network Editor in Chief Howard Bauchner, MD.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: